Company news: Zelira Therapeutics; Hygrovest; Epsilon Healthcare by Martin Lane September 22, 2022April 29, 2024 Zelira Therapeutics ASX-listed Zelira has launched licensable technology Zyraydi in a move it claimed would drive […]
Financial results: Avecho; AusCann; Zelira; Elixinol; Cann Group; Incannex; Creso Pharma; Medlab; Rua Bioscience by Steve Jones and Martin Lane September 1, 2022April 29, 2024
‘We needed an Aussie operation,’ says Creso boss, as expansion talks begin with Health House International by Steve Jones August 4, 2022April 29, 2024
Creso Pharma inks A$4.6m deal to buy Health House International by Martin Lane July 31, 2022April 29, 2024
Company news: LGP; Humacology; TSNG; Creso Pharma; ECS Botanics; Zelira; Cannasouth by Martin Lane July 14, 2022April 29, 2024
Zelira’s ‘multiple shots on goal’ will drive profitability, says global CEO by Steve Jones June 30, 2022April 29, 2024
Zelira’s Health House acquisition called off by Martin Lane and Steve Jones June 22, 2022April 29, 2024
Company news: Wellnex Life; Incannex; Tetra Bio-Pharma; Zelira by Martin Lane June 8, 2022April 29, 2024
Company news: Helius; Greenfern Industries; Zelira; Creso Pharma; Emyria; Roto-Gro International by Martin Lane June 2, 2022April 29, 2024
